231282 Changing pO2licy: The Elements for Improving Childhood Asthma Outcomes

Tuesday, November 9, 2010 : 1:05 PM - 1:10 PM

Yvonne U. Ohadike, PhD , Merck Childhood Asthma Network, Washington, DC
So many people think they know asthma – but they have no idea just how life threatening or costly it can be…especially when it comes to children. Through a series of compelling personal stories, dramatic graphics and moving narration, this video addresses that disconnect by bringing into focus the scope and severity of childhood asthma – the single most chronic disease among children in the United States. Rooted in the latest public health data on childhood asthma from the George Washington University School of Public Health and Health Services' new report, Changing pO2licy: The Elements for Improving Childhood Asthma Outcomes, the video places the issue in a context that is at once alarming and manageable. Zeroing in on a series of practical and evidence-based recommendations, the viewer leaves the video feeling empowered and hopeful that life can improve for the millions of children with asthma and their families.

Learning Areas:
Administer health education strategies, interventions and programs
Advocacy for health and health education
Chronic disease management and prevention
Public health or related education
Public health or related public policy

Learning Objectives:
The viewer will be able to explain the scope and severity of childhood asthma and policy changes that could improve childhood asthma outcomes.

Keywords: Asthma, Child Health

Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: The video does not include any reference to specific treatments.

Qualified on the content I am responsible for because: I am the Projects Evaluation Manager at the Merck Childhood Asthma Network, Inc.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.